NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2 | -71.4% | 3 | 0.0% | 0.00% | – |
| Q4 2022 | $7 | -99.6% | 3 | -97.1% | 0.00% | – |
| Q3 2020 | $2,000 | -96.9% | 103 | -97.2% | 0.00% | -100.0% |
| Q1 2020 | $65,000 | +38.3% | 3,652 | +70.8% | 0.00% | +100.0% |
| Q4 2019 | $47,000 | +840.0% | 2,138 | +1325.3% | 0.00% | – |
| Q3 2019 | $5,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -58.3% | 150 | -57.1% | 0.00% | -100.0% |
| Q1 2019 | $12,000 | +50.0% | 350 | +40.0% | 0.00% | 0.0% |
| Q4 2018 | $8,000 | -85.2% | 250 | -72.0% | 0.00% | -75.0% |
| Q3 2018 | $54,000 | +20.0% | 894 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $45,000 | +800.0% | 894 | +1688.0% | 0.00% | – |
| Q1 2018 | $5,000 | -16.7% | 50 | -50.0% | 0.00% | -100.0% |
| Q4 2017 | $6,000 | -14.3% | 100 | -75.0% | 0.00% | 0.0% |
| Q3 2016 | $7,000 | +16.7% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $6,000 | +200.0% | 400 | +100.0% | 0.00% | 0.0% |
| Q3 2015 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |